Bionik Laboratories Corp. announced that on August 30, 2022, Gerald Malone, an independent director of the Company, as well as the Chairman of its Compensation Committee and a member of its Audit Committee, resigned from all such positions with the Company. Mr. Malone's resignation as a director was not due to a disagreement with the Company on any matter relating to the Company's operations, policies or practices.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% |
|
-.--% | -.--% |
2023 | Bionik Laboratories Corp. Announces Executive Changes | CI |
2023 | Bionik Laboratories Corp. Reports Earnings Results for the Full Year Ended March 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 12 | |
-5.14% | 179B | |
-5.40% | 98.81B | |
-7.58% | 64.7B | |
+17.84% | 44.56B | |
-9.14% | 44.06B | |
+7.46% | 43.8B | |
+11.84% | 28.28B | |
+20.27% | 25.89B | |
-5.44% | 23.41B |
- Stock Market
- Equities
- BNKL Stock
- News Bionik Laboratories Corp.
- Bionik Laboratories Corp. Announces Resignation of Gerald Malone as Independent Director as Well as Chairman of Its Compensation Committee and Member of Its Audit Committee